# DESCRIPTION

## BACKGROUND

## SUMMARY

## DETAILED DESCRIPTION

### Incorporation of a GPI-Anchored Engineered Cytokine as a Molecular Adjuvant Enhances the Immunogenicity of HIV VLPs

### Pharmaceutical Compositions

### Methods of Use

### Combination Therapies

## EXPERIMENTAL

### Construction and Expression of GPI-Anchored GIFT4

### Production of HIV VLPs

### Functional Characterization of GIFT4-Containing VLPs

### Enhanced Antibody Avidity

